Ginsenoside Rc: A potential intervention agent for metabolic syndrome

Area of Science:

• Pharmacology
• Natural Products Chemistry
• Metabolic Disorders

Background:

• Ginsenoside Rc is a key compound from Panax ginseng.
• It exhibits diverse pharmacological activities.
• Metabolic syndrome (MetS) encompasses multiple related health issues.

Purpose of the Study:

• To review the sources, biosynthesis, extraction, and pharmacokinetics of ginsenoside Rc.
• To explore the anti-MetS effects of ginsenoside Rc across various phenotypes.
• To elucidate the molecular mechanisms underlying ginsenoside Rc's action.

Main Methods:

• Literature review focusing on ginsenoside Rc and MetS.
• Analysis of pharmacokinetic properties.
• Examination of signaling molecules influenced by ginsenoside Rc.

Main Results:

• Ginsenoside Rc demonstrates significant pharmacological effects against obesity, diabetes, atherosclerosis, NAFLD, and osteoarthritis.
• It modulates multiple signaling pathways involved in MetS.
• The compound acts on multiple organs and targets.

Conclusions:

• Ginsenoside Rc possesses multi-organ, multi-target, and multi-modal anti-MetS effects.
• Its safety and tolerability are established.
• Further clinical research is warranted, but it shows potential as a therapeutic agent for MetS.